News
Costs and prices of entecavir to treat Hepatitis B
2016-11-09 In an analysis of the costs and target prices of Hepatitis B treatment entecavir, author Andrew Hill from Liverpool University, UK and colleagues from Imperial… Read More »
Pharmacovigilance for mAbs
2016-11-07 Professor Pierre Michetti, a gastroenterologist at the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland in his paper discusses questions related to monoclonal antibody (mAb) biosimilars [1].… Read More »
US doctors poised to prescribe biosimilars
2016-11-04 A survey of specialists in the US has found that nearly half of them expect to prescribe biosimilars to treatment-naïve patients. The survey by healthcare… Read More »
Extrapolation of indications for mAbs
2016-11-02 Monoclonal antibody (mAb) biosimilars have recently entered the market, raising questions in the healthcare community. One of the questions discussed by Professor Pierre Michetti, a… Read More »
Impact of hypertension generics in Europe
2016-10-28 A report by the Germany-based Institute for Healthcare and Social Research (IGES) released in November 2015 found that generics of drugs to treat high blood… Read More »
Beyond biosimilarity
2016-10-26 The advent of monoclonal antibody (mAb) biosimilars has raised a series of questions in the healthcare community. Just a few of these questions were discussed… Read More »
Perception and knowledge of generics in Portugal
2016-10-24 Patients in Portugal are misinformed about generics, according to researchers from the Bragança Polytechnic Institute [1]. The study by Maria Ribeiro and co-authors analysed the… Read More »
Efficacy and safety of biosimilar infliximab compared to other biologicals in rheumatoid arthritis
2016-10-21 In the paper by Baji et al. [1], the authors carried out a meta-analysis to compare the efficacy and safety of biosimilar infliximab and other… Read More »
FDA includes follow-on versions in its new liposome guideline
2016-10-19 On 29 October 2015, the US Food and Drug Administration (FDA) issued a new draft guidance document for non-biological complex drugs (NBCDs). The new draft… Read More »
Measures to increase generics use in Greece
2016-10-17 Austerity has forced Greece to introduce a number of measures to reduce the amount it spends on healthcare. But how have measures aimed at increasing… Read More »